SPOTLIGHT -
Our Words of the Year 2021, and What They May Be Telling Us
Your words of 2021 are gathered. How did others describe the past pandemic year?
Reinforcement/Reward Mechanisms: Interventions for Executive Functioning
How do children with ADHD respond differently to reward and punishment, and how can we help them improve their executive functions?
ADHD, Infections, and the Immune System
What are the connections between ADHD, infectious diseases, and COVID-19?
Finding Common Ground in This Life
One doctor believes there are patients who will legitimately choose medical aid in dying—we just have to acknowledge them.
What Can Philosophy Learn From Madness?
Wouter Kusters, PhD, uses his experiences with psychosis to better inform his philosophy. What can we learn from him?
TAAR1 Agonism – A Novel Approach To Treating Schizophrenia
Addressing Shortages in the Psychiatry Workforce
The pandemic has worsened the psychiatry workforce shortage. What can we do about it?
Tender Fences
"...barriers that create space for healing placed close enough to hear everyone’s cries of longing and love..."
We Refuse to Hate
The recent hostage situation at a synagogue in Texas in indicative of a larger underlying problem.
It’s Time for Us to Realize We Are All on the Same Side
According to 1 doctor, we all need to communicate the legitimacy of psychiatry as a medical specialty.
Doorknob Moments: Why They Happen and How to Use Them
Expect the unexpected: how doorknob moments provide valuable new material to help you move treatment forward.
Introducing the APSARD Health Equity Task Force
How are minority children with ADHD affected by diagnostic, treatment, and educational inequities—and what can we do about it?
Everyone Relapses Anyway. Or Do They?
Approximately 7.6% of men and 4.1% of women aged 18 and older suffer from AUD, but national surveys consistently demonstrate low utilization of treatments.
Towards Dawn
One psychiatrist offers hope and a prayer for humanity as we enter the New Year.
January 17th, 2022: A Day of Great Social Psychiatric Implications
Several important events, all in 1 day.
King 3 Course Meal
Sex, Drugs, and ADHD
What is the connection between ADHD diagnosis with sexual activity and substance use among college students?
The College Experience for Students with ADHD
How does an ADHD diagnosis affect the college experience? Recent research allows the students to weigh in.
Did You Miss It? Adult ADHD Diagnosis
Is ADHD underdiagnosed or overdiagnosed? One doctor emphatically says the former.
The Variable You Can’t Touch: Advances in Mental Health Measurements
You cannot touch mental health impairments, so how best can we measure them? Adaptive testing may be the answer.
ADHD in Sexual and Gender Minority College Students
College students who identify as a sexual and gender minority who also have ADHD may be at higher risk of functional impairments, substance use, and psychiatric comorbidities.
Advances in Treatments for ADHD
What treatments were recently approved by the US Food and Drug Administration for pediatric patients with ADHD?
Helicopter Parenting & Adolescents With ADHD: Associations and Conclusions
Helicopter parenting in teens with ADHD: What are the types and how do they affect children?
Ethical and Moral Rationing Decisions in Medicine, Psychiatry, and the Pandemic
Rationing of crucial materials during the pandemic, like masks and vaccines, has become a matter of life and death.
What About the Little Guys: ADHD in Preschool
Ann Childress, MD, shares insights into ADHD in very young children at the 2022 APSARD Conference.
Musicians’ Mental Health in the Empire City During COVID-19
One resident interviews 2 NYC-based musicians about their experiences during the pandemic.
Chatbots for Child Mental Health Care: Helpful, but Limited
An estimated 7.7 million children have at least 1 mental health disorder. How can chatbots help?
The Psychological Worth of Our New Quarter
Maya Angelou and George Washington: now on two sides of the same coin.
More Than Money
It might be a token, but it says—and means—a lot...
Investigational New Drug Clearance Given to R-Ketamine
The FDA has given Investigational New Drug clearance for a clinical drug-drug interaction study of R-ketamine (PCN-101).